SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136696
Filing Date
2024-05-13
Accepted
2024-05-13 07:23:04
Documents
16
Period of Report
2024-05-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d810087d8k.htm   iXBRL 8-K 28738
2 EX-99.1 d810087dex991.htm EX-99.1 4637
7 GRAPHIC g810087g0513021353297.jpg GRAPHIC 2661
  Complete submission text file 0001193125-24-136696.txt   198973

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA autl-20240513.xsd EX-101.SCH 3236
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE autl-20240513_def.xml EX-101.DEF 13720
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE autl-20240513_lab.xml EX-101.LAB 22943
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE autl-20240513_pre.xml EX-101.PRE 14553
19 EXTRACTED XBRL INSTANCE DOCUMENT d810087d8k_htm.xml XML 5813
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 24936870
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)